Stockfacts
Use CasesDocsPricing
Log inSign up free
OverviewFinancialsTrendsTranscriptsOptionsInstitutionsInsidersCorporate ActionsSEC Filings
Stockfacts

EOD US-equity data for investors and AI agents

Data is end-of-day, not real-time, and not investment advice

Use CasesDashboard

BTAI

BioXcel Therapeutics, Inc.

CIK 0001720893 · Nasdaq

NasdaqHealth CarePharmaceutical Preparations
$0.84
↑ 0.04 (4.44%)
as of Jul 9, 2026
End-of-day close, not real-time intraday
Live price (Google Finance) ↗
Overall read: NeutralOverall score · based on 3/4 lenses
FundamentalsOwnershipTechnicalsOptions

Bullish: Fundamentals, Ownership; Risks: Technicals; Excluded: Options (no data)

Key stats

Market Cap
$25.87M
P/E Ratio
-0.34
EPS
-5.73
Dividend Yield
Not covered
52W Position
1%
Beta
2.55

Valuation multiples

Fwd P/E
Not covered
PEG
Not covered
P/B
-0.25
P/S
38.04
EV/Revenue
160.26
ROE
71.4%
Valuation data covers 8,503/9,463 US-listed stocks (89.9%).

Price · 1Y

251 trading days

End-of-day close, not real-time intraday

52-Week RangePosition 1%
$0.74$8.08

Latest Financials

2025-12-31 FY
Revenue
$642.00K
Net Income
-$69.90M
Total Assets
$44.92M
Free Cash Flow
-$57.62M

Recent news